All posts in Connecticut News

Michigan activists have filed a statewide ballot initiative that would legalize possessing, cultivating and sharing psychedelics and set up a system for their therapeutic and spiritual use. The national psychedelics advocacy group Decriminalize Nature, its Michigan chapter and the youth-led organization Students for Sensible Drug Policy (SSDP) are partnering on the effort. The Michigan ballot measure would legalize a range of entheogenic substances for adults 18 and older. Laws currently prohibiting psilocybin, psilocyn, ibogaine, mescaline, peyote and DMT would be affected by the policy change. “We are excited to have filed language with the state of Michigan, we look forward…

Concern over an increase in fentanyl-laced marijuana swept Connecticut after the state Department of Public Health reported potentially 39 overdoses on Nov. 18, but only one case was later found to be accurate. “The [Connecticut Overdose Response Strategy] assesses that the positive confirmation of marijuana with fentanyl was likely accidental contamination and an isolated incident,” Chris Boyle, a state health department spokesperson. Between July and October 2021, the state recorded 39 reports of “suspected” marijuana and fentanyl overdoses, Boyle said. In each of these cases, the person who overdosed claimed that they were only consuming marijuana, but experienced an opioid…

kmatija/E+ via Getty Images Investment Thesis Trulieve Cannabis Corp. (OTCQX:TCNNF) is the largest retailer of medical and recreational cannabis with 159 dispensaries in selected states in the US, including Florida, California, Massachusetts, Connecticut, Pennsylvania, and West Virginia. With an EBITDA margin in the range of 45% since FY2017, Trulieve reported an impressive revenue of $224.09M and an EBITDA of $91.5M in FQ3’21. It is in line with its closest competitors, Curaleaf Holdings, Inc (OTCPK:CURLF) and Green Thumb Industries Inc. (OTCQX:GTBIF), which reported revenues of $317.13M and $233.68M in FQ3’21, respectively. Despite the push for nationwide cannabis legalization, we expect the…

Sweeping cannabis bill sails through joint committee News > State-Region <span class="lightgalleryimg" data-src="/getattachment/02d5e839-5535-4303-afb4-bd563e73f754/a1masscanna-hg-020222-ph01" data-sub-html="Ryan McCartney trims leaves from maturing cannabis plants about a week before harvesting at the Holistic Industries cannabis cultivation and manufacture facility in Monson, April 16. GAZETTE FILE PHOTO/KEVIN GUTTING “> Ryan McCartney trims leaves from maturing cannabis plants about a week before harvesting at the Holistic Industries cannabis cultivation and manufacture facility in Monson, April 16. GAZETTE FILE PHOTO/KEVIN GUTTING State House News Service Published: 2/1/2022 8:25:51 PM Modified: 2/1/2022 8:24:21 PM BOSTON — There was no opposition in the Joint Committee on Cannabis Policy to…

Michigan activists have filed a statewide ballot initiative that would legalize possessing, cultivating and sharing psychedelics and set up a system for their therapeutic and spiritual use. The national psychedelics advocacy group Decriminalize Nature, its Michigan chapter and the youth-led organization Students for Sensible Drug Policy (SSDP) are partnering on the effort. The Michigan ballot measure would legalize a range of entheogenic substances for adults 18 and older. Laws currently prohibiting psilocybin, psilocyn, ibogaine, mescaline, peyote and DMT would be affected by the policy change. “We are excited to have filed language with the state of Michigan, we look forward…

Chicago-based cannabis company Verano Holdings Corp. announced a planned acquisition of Goodness Growth, which includes one of New York’s 10 vertically-integrated medical marijuana licenses. Verano announced on Monday that it entered into an agreement valued at $413 million with Minneapolis-based Goodness Growth – formerly known as Vireo Health. That expands Verano’s footprint into New York, as the state establishes its legal adult-use cannabis market. “We have always viewed New York as a strategic market to solidify our existing east coast presence, particularly ahead of the state’s adult-use rollout,” Verano CEO George Archos said. The deal is still subject to regulatory…

A three-judge panel of the U.S. Court of Appeals for the Ninth Circuit has rejected a lawsuit by cancer patients and their doctor seeking access to psilocybin—the main psychoactive compound in psychedelic mushrooms—to help treat end-of-life depression and anxiety. The patients and Seattle-based palliative care physician Dr. Sunil Aggarwal sued the U.S. Drug Enforcement Administration (DEA) in March, after the agency sent a letter saying there was no way for his clinic, the Advanced Integrative Medical Sciences (AIMS) Institute, to dispense a synthetic form of the psilocybin under state and federal right-to-try (RTT) laws. The laws allow patients with terminal conditions…

A three-judge panel of the U.S. Court of Appeals for the Ninth Circuit has rejected a lawsuit by cancer patients and their doctor seeking access to psilocybin—the main psychoactive compound in psychedelic mushrooms—to help treat end-of-life depression and anxiety. The patients and Seattle-based palliative care physician Dr. Sunil Aggarwal sued the U.S. Drug Enforcement Administration (DEA) in March, after the agency sent a letter saying there was no way for his clinic, the Advanced Integrative Medical Sciences (AIMS) Institute, to dispense a synthetic form of the psilocybin under state and federal right-to-try (RTT) laws. The laws allow patients with terminal conditions…